Skip to main content
TipRanks
Go Ultimate75% OFF

Crispr Therapeutics AG (1CG) Q4 2022 Earnings Report

22 Followers

DE:1CG Q4 2022 EPS Results

Actual EPS
-EUR 1.26
Consensus EPS
-EUR 2.01
Beat/Miss
Beat by +EUR 0.75
One Year Ago EPS
-EUR 1.65

DE:1CG Q4 2022 Revenue Results

Actual Revenue
EUR 5,372.098
Expected Revenue
EUR 6.38M
Beat/Miss
Missed by -EUR 6.37M
YoY Revenue Growth
-99.95%

Earnings Announcement Details

Quarter
Q4 2022
Date
02/21/2023
Time
After Close
Conference Call
Tuesday, February 21, 2023
DE:1CG Upcoming Earnings

Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:1CG Earnings History

DE:1CG earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272026 (Q4)-1.05--1.23――
Nov 02, 20262026 (Q3)-0.93-1.03-1.051.71% (+0.02)
Aug 03, 20262026 (Q2)-1.07-0.84-2.1560.83% (+1.31)
May 04, 20262026 (Q1)-1.09-1.15-1.4118.99% (+0.27)
Feb 12, 20262025 (Q4)-1.04-1.23-0.39-211.36% (-0.83)
Nov 10, 20252025 (Q3)-1.13-1.05-0.9-15.84% (-0.14)
Aug 04, 20252025 (Q2)-1.26-2.15-1.33-61.07% (-0.81)
May 06, 20252025 (Q1)-1.11-1.41-1.28-10.49% (-0.13)
Feb 11, 20252024 (Q4)-1.08-0.390.98-140.00% (-1.38)
Nov 05, 20242024 (Q3)-1.26-0.90-1.2628.37% (+0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed